Table 6.

—SNPs With eQTL Results

SNP	CHR	BP	eQTL P Value	Proportion of Variation Explained	CAMP or CAMP/Illumina Phenotype(s) With Nominal Association P Value
rs6754561	2	224547940	.95	0	…
rs6734100	2	224550239	…	…	AHR
rs7597833	2	224550394	.96	0	LogIgE
rs10164837	2	224555512	…	…	FEV1
rs975278	2	224555951	.97	0	…
rs6712954	2	224564894	…	…	LogIgE, FEV1/FVC
rs10191694	2	224565510	.064	0.052	…
rs6738983	2	224566994	.81	−0.007	FEV1/FVC
rs13396978	2	224568460	8.3 × 10−4	−0.11	…
rs11695803	2	224569405	0.77	0.009	…
rs3795879	2	224571065	…	…	FEV1/FVC
rs6747096	2	224571086	…	…	FEV1/FVC
rs3795877	2	224574421	2.8 × 10−5	0.14	FEV1/FVC
rs7590948	2	224581934	…	…	Asthma
rs7563931	2	224585805	0.65	−0.015	…
rs6436459	2	224588580	0.93	0.002	…
rs2037755	2	224591549	3.0 × 10−5	−0.14	Asthma
rs13008520	2	224597627	0.019	−0.069	…
rs10194024	2	224599084	3.0 × 10−11	0.27	Asthma
rs920251	2	224601189	1.4 × 10−20	−0.42	Asthma
rs6719480	2	224601673	7.3 × 10−12	0.28	…
rs1438831	2	224614559	4.7 × 10−18	0.39	Asthma
rs282254	2	224615591	8.9 × 10−12	−0.28	Asthma

eQTL entries containing an ellipse were not available. Negative values for proportion of variation explained denote that the minor allele confers reduced SERPINE2 transcript abundance relative to major allele. SERPINE2 = serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2. See Table 1, 3, and 4 legends for expansion of other abbreviations.